GSK vs WAFDP · P/E 13, $103.31B cap vs P/E 5.9, $2.32B cap
GlaxoSmithKline PLC ADR (GSK) versus WaFd, Inc. (WAFDP) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
WaFd, Inc. (WAFDP) is a banks - regional company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
WAFDP does not have a complete income-statement cache yet.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. WAFDP currently screens at market cap $2.32B and trailing P/E 5.9.
Not investment advice. Open the GSK and WAFDP stock pages for the full models.
Not investment advice.